MedPath

Comparison of pain reief with two different doses of the drug dexmedetomidine used in nerve block following one sided knee replacement surgery.

Phase 2
Conditions
Health Condition 1: M171- Unilateral primary osteoarthritisof knee
Registration Number
CTRI/2019/05/019307
Lead Sponsor
Department Funds
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient aged 18-85 years

2.ASA I , II & III

Exclusion Criteria

1)Patients refusal

2)Allergic to local anaesthetic

3)Patient on B Blockers and a agonist

4)Previously operated knee surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the analgesic efficacy of dexmedetomidine 0.5mcg/kg versus 1mcg/kg as an adjuvant to 0.2% ropivacaine in adductor canal block in patients undergoing unilateral total knee replacement surgeryTimepoint: Pain Score Post-operatively every 30 min for 2 hours and 4th hourly for 24 hours
Secondary Outcome Measures
NameTimeMethod
1)To assess the duration of analgesia. <br/ ><br>2)To compare motor blockade postoperatively. <br/ ><br>3)Postoperative sedation score. <br/ ><br>4)24 hour rescue analgesic consumption <br/ ><br>Timepoint: Postoperatively 30min for 2 hours and 4th hourly for 24 hours
© Copyright 2025. All Rights Reserved by MedPath